The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing gene medicines for B cell lymphomas.

Total Raised

$76 M

Rounds

1

Links

Verticals

Biopharma
Biotechnology
Health Care
Therapeutics

Investment History

  1. Series A

    May 2021

    $76M

Team

Philip R. Johnson

Chief Executive Officer

Saar Gill

Founder

Bruce A. Peacock

Co-Founder

Leticia Kuri Cervantes

Associate Director of Preclinical Biology